ExoAtlet, RVC Biofund Portfolio company, commences clinical trials of exoskeletons
ExoAtlet, RVC Biofund Portfolio company, invites volunteers with lower paraparesis to pilot medical exoskeletons for rehabilitation as part of clinical studies.
On June 28, 2016 ExoAtlet was registered as medical device in Rozdrav (its registration number РЗН 2016/4360).
On 1st of July RNRMU named after N.I. Pirogov started clinical trials of ExoAtlet® exoskeletons. It was the first round of the grant awarded by Skolkovo. The study will engage 24 pilots (volunteers) who have traumas of thoracic and lumbar spine or suffer from locomotion disorder but who are not completely paralysed. The study sets the objective of conducting comparative analysis of exoskeletons and classical methods of robotic mechanotherapy which have already been used for rehabilitation activities.
Similar robotic facilities of foreign origin can be seen in several Russian clinics , but their exorbitant price is inaccessible to the public.
12 pilots will take a course of 12 trainings based on functional electro myostimulation and individual physiotherapy. Other 12 participants will take a course based on standard methods of mechanotherapy and individual physiotherapy. The duration of rehabilitation course is 15 days for each patient.
ExoAtlet invites volunteers with lower paraparesis to pilot medical exoskeletons for rehabilitation as part of clinical studies. For terms and conditions or feedback address, please follow the link http://www.exoatlet.ru. In 2014 ExoAtlet reached the final of GenerationS Federal Competition organized by Russian Venture Company. In November 2015 Moscow Seed Fund jointly with RVC Biofund invested 16 million rubles in ExoAtlet company.
"EXOATLET" is a Russian-based manufacturer of medical exoskeletons. ExoAtlet project was initiated in 2011 by the Russian Ministry of Emergency Situations and a group of MSU scientists. Medical exoskeleton ExoAtlet® is designed to assist disabled people and it can be used for both physical and social rehabilitation of patients with musculoskeletal disorders. ExoAtlet® is a unique device designed to assist in verticalization and movement control of patients with locomotion disorders of lower limbs. It is suitable for patients with a wide range of diseases: its control system is based on signals from torque sensors, electromyograms. Control algorithms allow to perform the movement with constant repetition of natural walk patterns which speed up the recovery process of locomotor and nerve systems. ExoAtlet® is the example of human-robot integration.
RVC Biofund LLC is a biotech fund in the fund portfolio of RVC, OJSC. In its investment policy RVC's Biofund LLC focuses on innovative biopharmaceutical companies and service companies providing contract laboratory, analytical and consulting services to biotechnology, pharmaceutical and medical companies. RVC Biofund's portfolio includes nine design companies developing new drugs and analysis methods, as well as specialized services for biotechnology companie.
Moscow Seed Fund
The fund promoting the development of venture capital investments into small enterprises in scientific and technical sphere of Moscow City was established by the Department of Science, Industrial Policy and Entrepreneurship of Moscow City with the support of RVC OJSC. The Fund's mission is to support the venture investors beginners and young innovative enterprises. The Fund extends the loans against the concessionary interest rate for innovative projects under Seed and Pre-seed Stage that passed a competitive selection and received a financial aid as investments from private investors. The fund provides RUB 2 as a financial leverage for each RUB 1 invested by a private investor. The maximum amount of investments into one enterprise shall not exceed RUB 8 million. The loan is extended for 3 years.
